Open access
Editorial
29 April 2021

Alcohol product warning labels to deter alcohol misuse and prevent alcohol-related diseases: a call to action in Canada

Publication: Canadian Liver Journal
Volume 4, Number 2
Alcohol is consumed by 80% of the Canadian population, making it one of the most commonly used substances (1). 15% of alcohol users consume amounts greater than those recommended by the Canada’s Low Risk Drinking Guidelines, with young adults (those aged between 18 and 24 years) making up the largest proportion of these risk-taking drinkers (2). Short-term outcomes of alcohol use include motor vehicle accidents, violence, alcohol intoxication and withdrawal syndromes, risky sexual behaviour, alcoholic hepatitis, and fetal alcohol syndrome; and long-term health effects are not limited to liver, cardiac, oncological, and psychiatric diseases, some of which may be terminal (3,4). In 2017, 249 people per 100,000 were hospitalized as a result of alcohol use, and in 2014, 14,836 deaths were caused by alcohol misuse (2). Moreover, alcohol made up 36.2%, or $16.6 billion, of the total costs of substance use in 2017 (5). During the COVID-19 pandemic, 18% of those who stayed at home reported that their alcohol consumption increased (6). It is clear that alcohol use is a major public health and socio-economic concern in Canada (7).
Given these statistics, it is not surprising that the level of awareness of the negative health effects of alcohol is low among the general population. A survey conducted by the Canadian Cancer Society showed that only 28% of Ontario residents were aware of the linkage between alcohol and cancer (8). Two-thirds of those who were unaware claimed that they would decrease their alcohol consumption if they were informed about the linkage (8). In Prince Edward Island, only 22.3% of residents knew about the Low Risk Drinking Guidelines (9). Alcohol consumption, even excessive, was also rated as completely socially acceptable on a 5-point Likert scale by 56% of 9,215 participants in another Canadian survey (10).
As such, education is key to addressing this issue. One of the many actions that can be taken is to add warning labels to alcoholic products. Currently, no province has made these labels mandatory (11). However, studies conducted in Canada on the efficacy of warning labels show promising results. An interrupted study reported a 6.31% decrease in total per capita sales when labels on cancer risk, low-risk drinking guidelines, and standard drink information were introduced in Whitehorse, Yukon (12). Labels also increased awareness of and conversations about alcohol-related health effects and decreased consumption among participants in a quasi-experimental study (13). Graphic warning labels have been found to increase motivation to reduce alcohol consumption, with severe health warning labels being more effective than moderately severe ones (14,15). Studies in other countries have also shown positive effects of warning labels in combating alcohol use. In the United Kingdom, a randomized controlled trial found that participants preferentially selected non-alcoholic rather than alcoholic drinks when alcoholic beverages contained warning labels (16). More than 50% of women who participated in a cross-sectional survey in New Zealand agreed that warning labels provided a good source of information about the adverse effects of alcohol during pregnancy (17). Hence, strong evidence supports the fact that warning labels can be effective in reducing the burden caused by alcohol use when implemented properly.
In addition, it is important that warning labels are well designed. To achieve maximal benefits, labels should have clear messages about the health and social consequences of alcohol use, be attractive or attention grabbing, communicate a diverse set of messages instead of being repetitive, and make reference to others or the public in addition to the drinkers themselves (18,19). Larger-sized warning labels were shown to be associated with decreased ratings for alcoholic products among 440 adults in Nova Scotia (20). In addition to having health warnings on labels, a review suggested that the number of calories and a list of ingredients are useful information for drinkers (21).
However, warning labels cannot be expected to solve such a substantial societal issue on their own, and therefore additional educational initiatives will be necessary (18,19,22). Large-scale media campaigns have been successful in increasing awareness about the relationship between alcohol and cancer and increasing support for alcohol-related policies among the public (23). In Manitoba, a 30-second advertisement broadcast on television for about 2 months also increased awareness of the health effects of alcohol during pregnancy (24). School-based prevention programs are also effective in reducing rates of alcohol use (25,26). A combined and integrated approach that involves all of these initiatives increases the chances of bringing about significant behavioural and attitude changes.
It is hoped that rates of alcohol misuse among Canadians will improve, just as dramatic declines were seen in smoking rates through similar mass awareness campaigns, preventive programs, and policy changes, including mandatory warning labels on tobacco packaging (27). It is now the duty and responsibility of public health agencies and policy-makers to ignite and implement needed interventions to protect and save Canadians who are currently ignorant of the many harms of alcohol. At the very least, a product warning label on a bottle of alcohol will inform consumers that a higher authority (ie, the government) takes the risks seriously enough to require a safety label; for some, it may be the only source of information they see. As with cigarette product warnings, the benefits may not be appreciated for years or even decades, but any long journey must begin with a first step, and this first step is long overdue.

Funding:

No funding was received for this article.

References

2.Canadian Centre on Substance Use and Addiction. Alcohol (Canadian drug summary). https://www.ccsa.ca/alcohol-canadian-drug-summary (Accessed February 16, 2021).
3.World Health Organization. Alcohol. https://www.who.int/news-room/fact-sheets/detail/alcohol (Accessed February 20, 2021).
4.Centers for Disease Prevention and Control. Alcohol use and your health. https://www.cdc.gov/alcohol/fact-sheets/alcohol-use.htm (Accessed February 20, 2021).
5.Stockwell T, Dorocicz J, Sherk A, Sorge J, Zhao J. Canadian substance use costs and harms (2015-2017). https://www.ccsa.ca/canadian-substance-use-costs-and-harms-2015-2017-report (Accessed February 20, 2021).
6.Nanos. 25% of Canadians (aged 35-54) are drinking more while at home due to COVID-19 pandemic; cite lack of regular schedule, stress and boredom as main factors. https://www.ccsa.ca/sites/default/files/2020-04/CCSA-NANOS-Alcohol-Consumption-During-COVID-19-Report-2020-en.pdf (Accessed February 20, 2021).
7.Ahmad P. Impacts of COVID-19 disproportionately affect poor and vulnerable: UN chief. https://news.un.org/en/story/2020/06/1067502 (Accessed September 6, 2020).
8.Canadian Cancer Society. The truth about alcohol. https://www.cancer.ca/en/about-us/news/on/2016/february/story4/?region=on (Accessed February 20, 2021).
9.McNally K, Noonan LL, Cameron M, Phillips K, Baidoobonso S, Sabapathy D. Public awareness of low-risk alcohol use guidelines. Health Promot Pract. 2019;20(6):905–13. https://doi.org/10.1177/1524839918781527. Medline:29907073
10.Government of Canada. Canadian cannabis survey 2017—summary. https://www.canada.ca/en/health-canada/services/publications/drugs-health-products/canadian-cannabis-survey-2017-summary.html (Accessed February 20, 2021).
11.Giesbrecht N, Scientist S, Wettlaufer A, et al. Strategies to reduce alcohol-related harms and costs in Canada: a comparison of provincial policies. Toronto: Centre for Addiction and Mental Health; 2013.
12.Zhao J, Stockwell T, Vallance K, Hobin E. The effects of alcohol warning labels on population alcohol consumption: an interrupted time series analysis of alcohol sales in Yukon, Canada. J Stud Alcohol Drugs. 2020;81(2):225–37. https://doi.org/10.15288/jsad.2020.81.225. Medline:32359054
13.Hobin E, Shokar S, Vallance K, et al. Communicating risks to drinkers: testing alcohol labels with a cancer warning and national drinking guidelines in Canada. Can J Public Health. 2020;111(5):716–25. https://doi.org/10.17269/s41997-020-00320-7. Medline:32458295
14.Pechey E, Clarke N, Mantzari E, et al. Image-and-text health warning labels on alcohol and food: potential effectiveness and acceptability. BMC Public Health. 2020;20(1):376. https://doi.org/10.1186/s12889-020-8403-8. Medline:32238154
15.Sillero-Rejon C, Attwood AS, Blackwell AKM, Ibáñez-Zapata JA, Munafò MR, Maynard OM. Alcohol pictorial health warning labels: the impact of self-affirmation and health warning severity. BMC Public Health. 2018;18(1):1403. https://doi.org/10.1186/s12889-018-6243-6. Medline:30577730
16.Clarke N, Pechey E, Mantzari E, et al. Impact of health warning labels communicating the risk of cancer on alcohol selection: an online experimental study. Addiction. 2021;116(1): 41–52. https://doi.org/10.1111/add.15072. Medline:32267588
17.Parackal SM, Parackal MK, Harraway JA. Warning labels on alcohol containers as a source of information on alcohol consumption in pregnancy among New Zealand women. Int J Drug Policy. 2010;21(4):302–5. https://doi.org/10.1016/j.drugpo.2009.10.006. Medline:19931445
18.Wilkinson C, Room R. Warnings on alcohol containers and advertisements: International experience and evidence on effects. Drug Alcohol Rev. 2009;28:426–35. https://doi.org/10.1111/j.1465-3362.2009.00055.x.
19.Thomas G, Gonneau G, Poole N, Cook J. The effectiveness of alcohol warning labels in the prevention of fetal alcohol spectrum disorder: a brief review. Int J Alcohol Drug Res. 2014;3(1):91–103. https://doi.org/10.7895/ijadr.v3i1.126
20.Al-Hamdani M, Smith SM. Alcohol warning label perceptions: do warning sizes and plain packaging matter? J Stud Alcohol Drugs. 2017;78(1):79–87. https://doi.org/10.15288/jsad.2017.78.79. Medline:27936367
21.Martin-Moreno JM, Harris ME, Breda J, MØller L, Alfonso-Sanchez JL, Gorgojo L. Enhanced labelling on alcoholic drinks: Reviewing the evidence to guide alcohol policy. Eur J Public Health. 2013;23:1082–7. https://doi.org/10.1093/eurpub/ckt046
22.Thomson LM, Vandenberg B, Fitzgerald JL. An exploratory study of drinkers views of health information and warning labels on alcohol containers. Drug Alcohol Rev. 2012;31(2):240–7. https://doi.org/10.1111/j.1465-3362.2011.00343.x. Medline: 21824209
23.Christensen ASP, Meyer MKH, Dalum P, Krarup AF. Can a mass media campaign raise awareness of alcohol as a risk factor for cancer and public support for alcohol related policies? Prev Med (Baltim). 2019;126:105722. https://doi.org/10.1016/j.ypmed.2019.05.010.
24.Casiro OG, Stanwick RS, Pelech A, Taylor V. Public awareness of the risks of drinking alcohol during pregnancy: the effects of a television campaign. Can J Public Health. 1994;85(1):23–7.
25.Sussman S, Dent CW, Stacy AW. Project Towards No Drug Abuse: a review of the findings and future directions. Am J Health Behav. 2002;26(5):354–65. https://doi.org/10.5993/AJHB.26.5.4. Medline:12206445
26.Agabio R, Trincas G, Floris F, Mura G, Sancassiani F, Angermeyer MC. A systematic review of school-based alcohol and other drug prevention programs. Clin Pract Epidemiol Ment Health. 2015;11(1):102–12. https://doi.org/10.2174/1745017901511010102. Medline: 25834630
27.Statistics Canada. Current smoking trends. https://www150.statcan.gc.ca/n1/pub/82-624-x/2012001/article/11676-eng.htm (Accessed February 20, 2021).

Information & Authors

Information

Published In

Go to Canadian Liver Journal
Canadian Liver Journal
Volume 4Number 2Spring 2021
Pages: 75 - 78

History

Published in print: Spring 2021
Published online: 29 April 2021

Keywords:

  1. alcohol use
  2. health warning labels
  3. policy

Authors

Affiliations

Man Ting Kristina Yau, BSc
Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada
Natasha Chandok, MD, MPH, FRCPC
Division of Gastroenterology, William Osler Health System, Brampton, Ontario, Canada
Eric M Yoshida, MD, MHSc,FRCPC
Division of Gastroenterology, University of British Columbia, Vancouver, British Columbia, Canada

Notes

Correspondence: Eric M Yoshida, Vancouver General Hospital, Diamond Health Care Centre, 5153-2775 Laurel Street, Vancouver, British Columbia V5Z 1M9 Canada. Telephone: 604-875-5371. Fax: 604-638-2419. Email: [email protected]

Contributions:

Conceptualization, MTKY, NC, EMY; Writing – Original Draft, MTKY, NC, EMY; Writing – Review & Editing, MTKY, NC, EMY.

Disclosures:

There are no disclosures to declare.

Metrics & Citations

Metrics

VIEW ALL METRICS

Related Content

Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

Format





Download article citation data for:
Man Ting Kristina Yau, Natasha Chandok, and Eric M Yoshida
Canadian Liver Journal 2021 4:2, 75-78

View Options

View options

PDF

View PDF

EPUB

View EPUB

Restore your content access

Enter your email address to restore your content access:

Note: This functionality works only for purchases done as a guest. If you already have an account, log in to access the content to which you are entitled.

Figures

Tables

Media

Share

Share

Copy the content Link

Share on social media

About Cookies On This Site

We use cookies to improve user experience on our website and measure the impact of our content.

Learn more

×